Filter by: Subject

Filter by: Subject

Results Per Page:

Streptococcus pneumoniae (15)
Pneumococcus (14)
Community-acquired pneumonia (CAP) (10)
Pneumolysin (9)
Platelets (8)
Human immunodeficiency virus (HIV) (7)
Macrolides (7)
Community-acquired pneumonia (6)
Neutrophils (6)
Antibiotics (5)
Calcium (5)
Pneumonia (5)
Biomarkers (4)
Inflammation (4)
Mortality (4)
Smoking (4)
Tuberculosis (TB) (4)
Antibiotic resistance (3)
Cardiac complications (3)
CD62P (3)
Corticosteroids (3)
Hydrogen peroxide (3)
Infection (3)
Platelet-activating factor (3)
Reactive oxygen species (3)
Risk factors (3)
Thrombocytopenia (3)
Treatment (3)
Vaccination (3)
Adhesins (2)
Antiretroviral therapy (ART) (2)
Calcium fluxes (2)
Cardiovascular event (CVE) (2)
Catecholamines (2)
Cigarette smoke condensate (2)
Clarithromycin (2)
Combination antiretroviral therapy (cART) (2)
Critical illness (2)
Dolutegravir (DTG) (2)
Elastase (2)
Fluoroquinolones (2)
Immunopathogenesis (2)
Innate immune system (2)
Intensive care unit (ICU) (2)
Invasive pneumococcal disease (IPD) (2)
Johannesburg, South Africa (2)
Macrolide antibiotics (2)
Macrolide resistance (2)
Mineralocorticoids (2)
P-selectin (2)
Pathogenesis (2)
Patients (2)
Pneumococcal disease (2)
Pneumococcal infections (2)
Pro-inflammatory activity (2)
SDG-03: Good health and well-being (2)
Sepsis (2)
Thrombocytosis (2)
Toll-like receptors (2)
5-lipoxygenase (1)
Active pulmonary tuberculosis (1)
Acute cardiac events (1)
Acute cardiovascular event (ACE) (1)
Acute myocardial infarction (AMI) (1)
Acute phase response (1)
Adenosine 50-diphosphate (1)
Adenosine-5′-triphosphate (1)
Adjunctive therapy (1)
Adjuvant therapy (1)
Adolescents (1)
Adrenal insufficiency (1)
Airway disorders (1)
Airway epithelial cells (1)
Angiogenesis (1)
Anti-inflammatory (1)
Anti-inflammatory activity (1)
Anti-inflammatory agents -- Research -- South Africa (1)
Anti-inflammatory properties (1)
Anti-platelet agents (1)
Antibacterial agents -- Research (1)